Who Owns Boston Scientific?
Updated onExplore the ownership hierarchy of Boston Scientific. See parent companies, holding structures, and ultimate controllers.
Ownership Chain
Boston Scientific
Boston Scientific is a global medical technology company that develops and manufactures minimally invasive medical devices used to diagnose and treat a wide range of health conditions.
Boston Scientific appears to be independent with no known parent company.
Boston Scientific
Boston Scientific is a global medical technology company that develops and manufactures minimally invasive medical devices used to diagnose and treat a wide range of health conditions.
Boston Scientific appears to be independent with no known parent company.
Major Shareholders
Boston Scientific
Major Shareholders
| Name | Type | Ownership | As of |
|---|---|---|---|
BlackRock Inc. Largest institutional shareholder based on reported holdings of Boston Scientific common stock; ownership via various BlackRock funds and accounts. | Institutional | 9.8% | Sep 2025 |
The Vanguard Group, Inc. Major index and active asset manager holding Boston Scientific shares on behalf of investors. | Institutional | 9.3% | Sep 2025 |
FMR LLC (Fidelity Investments) Large U.S. asset manager; beneficial owner of Boston Scientific shares through Fidelity-branded funds and accounts. | Institutional | 6.7% | Sep 2025 |
State Street Corporation Custody bank and asset manager (including State Street Global Advisors) holding Boston Scientific shares for institutional and ETF clients. | Institutional | 4.4% | Sep 2025 |
JPMorgan Chase & Co. Global bank and asset manager with Boston Scientific holdings across its investment management businesses. | Institutional | 3.8% | Sep 2025 |
Promerica LP Long‑standing insider limited partnership and major direct shareholder of Boston Scientific; current stake estimated from recent ownership aggregators at about 3.7% of outstanding shares. | Institutional | 3.7% | — |
Bank of America Corporation Major U.S. financial institution holding Boston Scientific shares through its investment and wealth management units. | Institutional | 2.3% | Sep 2025 |
PRIMECAP Management Company Independent investment manager with a significant active position in Boston Scientific. | Institutional | 2.2% | Sep 2025 |
Geode Capital Management, LLC Institutional asset manager that sub-advises index portfolios, including those used by Vanguard, with sizable Boston Scientific holdings. | Institutional | 2.2% | Sep 2025 |
Capital World Investors (Capital Research and Management Company) Division of Capital Group managing American Funds; holds Boston Scientific shares across multiple mutual funds. | Institutional | 1.8% | Sep 2025 |
Morgan Stanley Global investment bank and asset manager with Boston Scientific positions in client and proprietary accounts. | Institutional | 1.4% | Sep 2025 |
Get Started
Your ultimate competitive playbook
You just found your top competitors. Now let's map your whole landscape and show you how to stand out.
Competitive Landscape Report
Built for small teams who can't hire a full-time analyst.
$129 $260 one-time payment
Generated in minutes, no subscription.
Instead of guessing what to do about your competitors, get a done-for-you intelligence report
Competitor Map
Direct, indirect, and alternative competitors mapped across your market
Positioning Analysis
How each competitor positions, their ICP, and key differentiators
Feature & Pricing Matrix
Side-by-side comparison of features, pricing, and packaging strategies
Growth Channel Analysis
SEO, paid ads, content, and social strategies across the landscape
Reputation & Social Proof
Ratings, reviews, and sentiment analysis across all competitors
90-Day Action Plan
Specific tactics to differentiate and win more deals in the next 3 months